Inventor · disambiguated record
Scott Ribich
Also filed as: RIBICH SCOTT
2 granted patents·12 pending applications·10 citations·filing 2017–2024
57Inventor score
Top patents by PatentIndex Score
14 records- 0187US11147819B2EZH2 inhibitors for treating cancerEPIZYME INC·Filed 2017·Granted Oct 19, 2021·6 cites·29 claims
- 0283US11786533B2Use of EZH2 inhibitors for treating cancerEPIZYME INC·Filed 2017·Granted Oct 17, 2023·4 cites·15 claims
- 0380US2025145597A1Inhibitors of rna helicase dhx9 and uses thereofACCENT THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0472US2024180919A1Ezh2 inhibitors for treating cancerEPIZYME INC·Filed 2023·Application pending·0 cites
- 0570US2022160721A1Methods of treating cancerEPIZYME INC·Filed 2021·Application pending·0 cites
- 0667US2024139203A1Use of ezh2 inhibitors for treating cancerEPIZYME INC·Filed 2023·Application pending·0 cites
- 0763US2020323865A1Methods of treating cancerEPIZYME INC·Filed 2020·Application pending·0 cites
- 0862US2022105098A1Ezh2 inhibitors for treating cancerEPIZYME INC·Filed 2021·Application pending·0 cites
- 0961US2023046656A1Crebbp related cancer therapyEPIZYME INC·Filed 2022·Application pending·0 cites
- 1058US2022175771A1Cancer treatment modalitiesEPIZYME INC·Filed 2021·Application pending·0 cites
- 1157US2025179013A1Inhibitors of rna helicase dhx9 and uses thereofACCENT THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1257US2019038633A1Methods of treating cancerEPIZYME INC·Filed 2017·Application pending·0 cites
- 1341US2019350929A1Cancer treatment modalitiesEPIZYME INC·Filed 2018·Application pending·0 cites
- 1440US2019270797A1Crebbp related cancer therapyEPIZYME INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Ribich files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →